ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

In Brief: Grants Compromise Still In Doubt As Natcher, Conte Hold Out for 6,500; House Marks Up Bill

July 12, 1985

In Brief: Mass. Selects Hoh As Health Commissioner; Komen Foundation Selects Research Fellows

August 8, 1997

Moffitt To Enhance Information For Brain Tumor Patients.

July 13, 2001

Studies Started On Use Of Heroin, THC for Pain, Discomfort Therapy

October 13, 1978